Market revenue in 2023 | USD 314.3 million |
Market revenue in 2030 | USD 776.6 million |
Growth rate | 13.8% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Products Type |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Horizon Discovery, NanoString Technologies, Merck KGaA, Takara Bio Inc, LGC Group, Biogenex, New England Biolabs, GeneCopoeia |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microrna market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 60.29% in 2023. Horizon Databook has segmented the Asia Pacific microrna market based on services, products type covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific microrna market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific microrna market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account